PartsTable
Technical Data Sheet
Download PDF

NDC00006-3331-60 — THIABENDAZOLE ORAL SUSPENSION

✓ Government record, cited
— · COMPONENT
PRODUCT OVERVIEW

NDC00006-3331-60: THIABENDAZOLE ORAL SUSPENSION.

The THIABENDAZOLE ORAL SUSPENSION is a the manufacturer industrial component. Key specifications include primary_container_type: BOTTLE, pharmaceutical_vehicle_type: AQUEOUS, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 120.000 MILLILITERS, active_medicament_medicinal_strength: 100.000 MILLIGRAMS THIABENDAZOLE ACTIVE INGREDIENT, part_name_assigned_by_controlling_agency: THIABENDAZOLE ORAL SUSPENSION USP 100MG 120ML BT. This part is cataloged in the U.S.

Government catalog under NSN 6505-00-935-5835, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS
NDC00006-3331-60
NSN: 6505-00-935-5835
FSC: 6505 — Drugs and Biologicals
CAGE: 06990 — MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH (USA)
SPECIFICATIONS
primary_container_typeBOTTLE
pharmaceutical_vehicle_typeAQUEOUS
medical_designation_and_gradeUNITED STATES PHARMACOPEIA
primary_container_content_quantity120.000 MILLILITERS
active_medicament_medicinal_strength100.000 MILLIGRAMS THIABENDAZOLE ACTIVE INGREDIENT
part_name_assigned_by_controlling_agencyTHIABENDAZOLE ORAL SUSPENSION USP 100MG 120ML BT
NSN6505-00-935-5835
COMPONENT DIAGRAM
COMPONENT MAIN IC EDGE CONNECTOR No detailed specs available THIABENDAZOLE ORAL SUSPENSION TITLE COMPONENT PN NDC00006-3331-60 MFR THIABENDAZOLE ORAL SUS
KEY FEATURES
•
PRIMARY CONTAINER CONTENT QUANTITY: 120.000 MILLILITERS
•
MEDICAL DESIGNATION AND GRADE: UNITED STATES PHARMACOPEIA
•
PRIMARY CONTAINER TYPE: BOTTLE
•
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
•
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS THIABENDAZOLE ACTIVE INGREDIENT
TECHNICAL CHARACTERISTICS
PRIMARY CONTAINER CONTENT QUANTITY120.000 MILLILITERS
MEDICAL DESIGNATION AND GRADEUNITED STATES PHARMACOPEIA
PRIMARY CONTAINER TYPEBOTTLE
PART NAME ASSIGNED BY CONTROLLING AGENCYTHIABENDAZOLE ORAL SUSPENSION USP 100MG 120ML BT
PHARMACEUTICAL VEHICLE TYPEAQUEOUS
ACTIVE MEDICAMENT MEDICINAL STRENGTH100.000 MILLIGRAMS THIABENDAZOLE ACTIVE INGREDIENT
SUBSTITUTES & CROSS-REFERENCES 2
MINTEZOL SUSPENSIONReference document
Same NSN cross-reference
Reference document — Secondary reference
MINTEZOLReference document
Same NSN cross-reference
Reference document — Secondary reference
LIFECYCLE
NSN statusActive· U.S. Government catalog
Shelf-life managedAcquisition advice: Terminal item — stock exhausted; no further procurementNo demilitarization required
Ready to buy NDC00006-3331-60?
Compare prices from verified sellers on eBay
Buy on eBay →
As an eBay Partner, PartsTable may earn a commission. Your price is not affected.
FREQUENTLY ASKED QUESTIONS
What is NDC00006-3331-60?
NDC00006-3331-60 is a THIABENDAZOLE ORAL SUSPENSION.
What parts can replace NDC00006-3331-60?
There are 2 known substitutes for NDC00006-3331-60: MINTEZOL SUSPENSION, MINTEZOL. Substitute compatibility should be verified for your specific system.
What is the NSN for NDC00006-3331-60?
NDC00006-3331-60 is cataloged in the U.S. Government catalog under NSN 6505-00-935-5835. This indicates validated use in U.S. government and defense supply chains.
Community Feedback
Leave a Comment
Comments are reviewed before appearing. You will receive an email to verify before your comment appears.

Request a Quote — NDC00006-3331-60

✓ PartsTable — the parts reference. Every fact cited to its source.
PartsTable Design LLC · partstable.com
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.
PartsTable commercial catalog: edition Unified commercial catalog snapshot through 2026-09-28, edition date not on file, retrieved 2026-09-28.